Forte Biosciences, Inc. (FBRX)
NASDAQ·Healthcare·Biotechnology
$26.49
-1.16%
Mkt Cap $381.16M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 31, 2026 | — | — | — | -$1.42 | -$1.45 | -2.11% | — | — |
| Q4 2025 Nov 14, 2025 | — | — | — | -$1.04 | -$0.99 | +4.81% | — | — |
| Q3 2025 Aug 14, 2025 | — | — | — | -$1.21 | -$0.96 | +20.66% | — | — |
| Q2 2025 May 15, 2025 | — | — | — | -$0.89 | -$1.37 | -53.93% | — | — |
| Q1 2025 Mar 24, 2025 | — | — | — | -$4.55 | -$2.45 | +46.15% | — | — |
| Q4 2024 Nov 14, 2024 | — | — | — | -$6.75 | -$4.54 | +32.74% | — | — |
| Q3 2024 Aug 14, 2024 | — | — | — | -$4.00 | -$6.75 | -68.75% | — | — |
| Q2 2024 May 13, 2024 | — | — | — | -$0.16 | -$4.00 | -2400.00% | — | — |
| Q1 2024 Mar 18, 2024 | — | $6.00K | — | -$0.28 | -$1.00 | -257.14% | — | — |
| Q4 2023 Nov 13, 2023 | — | — | — | -$14.25 | -$6.50 | +54.39% | — | — |
| Q3 2023 Aug 14, 2023 | — | — | — | — | -$10.50 | — | — | — |
| Q2 2023 May 15, 2023 | — | — | — | — | -$8.00 | — | — | — |
| Q1 2023 Mar 31, 2023 | — | — | — | -$0.16 | -$6.00 | -3650.00% | — | — |
| Q4 2022 Nov 14, 2022 | — | — | — | -$0.15 | -$4.50 | -2900.00% | — | — |
| Q3 2022 Aug 15, 2022 | — | — | — | -$0.17 | -$5.25 | -2988.24% | — | — |
| Q2 2022 May 16, 2022 | — | — | — | -$0.17 | -$4.25 | -2400.00% | — | — |
| Q1 2022 Mar 31, 2022 | — | — | — | -$0.07 | -$5.25 | -7400.00% | — | — |
| Q4 2021 Nov 8, 2021 | — | — | — | -$7.25 | -$13.50 | -86.21% | — | — |
| Q3 2021 Aug 16, 2021 | — | — | — | -$10.00 | -$10.75 | -7.50% | — | — |
| Q2 2021 May 10, 2021 | — | — | — | -$9.75 | -$9.00 | +7.69% | — | — |